GoodRx Expands Access to Eli Lilly and Company’s New Oral GLP-1, Foundayo™, and Zepbound® KwikPen® with Self-Pay Pricing at More Than 70,000 Pharmacies Nationwide
GoodRx Holdings, Inc. - Class A (GDRX)
Company Research
Source: Business Wire
Eligible self-pay consumers can access Foundayo starting at $149 per month through GoodRxBrief Summary:GoodRx is expanding access to the newly FDA-approved oral GLP-1 medication, Foundayo™ (orforglipron)Eligible self-pay consumers can access Foundayo starting at $149 per month through GoodRxGoodRx is also offering self-pay pricing for Zepbound® (tirzepatide) KwikPen® starting at $299 per monthFoundayo and Zepbound KwikPen are available through GoodRx’s nationwide pharmacy networkGoodRx is helping pharmaceutical manufacturers deliver consumer-direct pricing at scale from day one SANTA MONICA, Calif.--(BUSINESS WIRE)--GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that it is working with Eli Lilly and Company to expand access to the newly FDA-approved oral GLP-1 medication, Foundayo™ (orforglipron). Eligible self-pay patients can access Foundayo through GoodRx at a starting price of $149 per month, in line with the lowest available d
Show less
Read more
Impact Snapshot
Event Time:
GDRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GDRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GDRX alerts
High impacting GoodRx Holdings, Inc. - Class A news events
Weekly update
A roundup of the hottest topics
GDRX
News
- Stay Protected on Vacation With 40% Off the Ring Outdoor Cam Plus [CNET News]CNET News
- How to Navigate Prescription Drug Discount Websites [MSNBC.com]MSNBC.com
- The Eufy Video Doorbell E340 Can Act as a Security Guard for Your Front Door. It's Now Over $100 Off [CNET News]CNET News
- Paying cash for healthcare: Can it save you money? [Yahoo! Finance]Yahoo! Finance
- Hims & Hers Advances a Consumer-Centric Digital Health Platform [Yahoo! Finance]Yahoo! Finance
GDRX
Earnings
- 2/25/26 - Beat
GDRX
Sec Filings
- 4/3/26 - Form 8-K
- 3/27/26 - Form 8-K
- 3/27/26 - Form SCHEDULE
- GDRX's page on the SEC website